Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Balance Sheet Components
Accrued commercial and research and development manufacturing	$ 17,055	$ 23,470
Accrued co-development costs and milestone payments	12,500	26,812
Accrued royalties	3,583	42,031
Royalty Fee Derivative Liability (Note 8)	9,202
Revenue participation liability, current (Note 8)	2,682
Accrued other	14,586	7,628
Lease liabilities, current	1,436	2,145
Contingent consideration, current		3,300
Total Accrued and other current liabilities	$ 61,044	$ 105,386